VIVO - Meridian Bioscience Inc Profile, Share Price, Market Analysis, Charts, Fundamentals - CSIMarket

Company Name, Ticker, Suppliers, else..

Meridian Bioscience Inc (VIVO)

Other Ticker:

Sector • Healthcare Industry • In Vitro & In Vivo Diagnostic Substances

Industry • In Vitro & In Vivo Diagnostic Substances

Sector • Healthcare

Price: $30.4200 $-1.08

-3.429%

Day's High:	$31.241	Week Perf:	1.4 %
Day's Low:	$ 29.90	30 Day Perf:	10.62 %
Volume (M):	805	52 Wk High:	$ 31.93
Volume (M$):	$ 24,479	52 Wk Avg:	$22.44
Open:	$31.09	52 Wk Low:	$17.04

VIVO Charts & Quotes

VIVO Charts & Quotes

Company's Segments

Market Capitalization (Millions $)	1,346
Shares Outstanding (Millions)	44
Employees	-
Revenues (TTM) (Millions $)	339
Net Income (TTM) (Millions $)	62
Cash Flow (TTM) (Millions $)	13
Capital Exp. (TTM) (Millions $)	10

Meridian Bioscience Inc

Company Address: 3471 River Hills Drive Cincinnati 45244 OH
Company Phone Number: 271-3700 Stock Exchange / Ticker: NASDAQ VIVO

VIVO is expected to report next financial results on August 05, 2022.

Reports on Competition

List of Competitors

Competitors by Segment

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Stock Performances by Major Competitors

Year to Date	Decrease / Increase

• View Complete Report

News

Pure Storage Inc.

Redemption of Losses, Sales very Strong

Strong Sales growth in the fiscal time-frame ending May 08 2022, by 50.33% to $620.41 millions helped to cut the loss to $-0.04 per share, from $-0.30 in same quarter a year ago.

Infosys Limited

Income Increased by 14.75 %, Surge in Sales

In the fourth quarter of 2022 earnings season Infosys Limited eps grew by 14.75 % of $0.70 per share compared to $0.61 a year ago and from $0.00 per share from the previous quarter.

Nami Corp.

Nami Corp declared a same Sales like a year ago in the fiscal interval ending Mar 31 2022

Nami Corp announced operating shortfall of $-0.232862 millions, in the fiscal interval ending Mar 31 2022, a change from the operating shortfall of $-0.020206 millions, recorded in the same quarter a year ago.

Riverview Bancorp Inc

Revenues and Eps Grew in Double Digits at Riverview Bancorp Inc in the fourth quarter of 2022

Company reported double digit Revenue and earnings growth in the fourth quarter of 2022. Revenues were at $15.52 millions up by 10.62% year on year and decreased by -5.64 % quarter on quarter, while earnings were up by 22.28 % to $0.19, sequentially income faded by -25.58 %.

Zeuus Inc

Break-even by Zeuus Inc in the most recent fiscal period release

Zeuus Inc announced operating shortfall of $-0.178315 millions, in the most recent fiscal period, a change from the operating shortfall of $-0.051327 millions, recorded in the same quarter a year ago.

VIVO's Valuation	Current
Price to Earnings PE Ratio (TTM)	21.56
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	3.97
Price to Sales (Expected)	-
Price to Book	3.59
PEG (TTM)	-

VIVO's Financial Strength	Current
Quick Ratio	1.35
Working Capital Ratio	3.85
Leverage Ratio (MRQ)	0.26
Total Debt to Equity	0.07
Interest Coverage (TTM)	61.33
Debt Coverage (TTM)	2.1

Per Share	Current
Earnings (TTM)	1.41 $
Revenues (TTM)	7.67 $
Cash Flow (TTM)	0.3 $
Cash	1.73 $
Book Value	8.46 $
Dividend (TTM)	0 $

VIVO's Efficiency	Current
Revenue per Employee (TTM)	-
Net Income per Employee (TTM)	-
Receivable Turnover Ratio (TTM)	6.81
Inventory Turnover Ratio (TTM)	1.9
Asset Turnover Ratio (TTM)	0.74

VIVO's Profitability Ratio	Current
Gross Margin (MRQ)	61.56 %
Operating Margin (MRQ)	32.49 %
Net Margin (MRQ)	25.85 %
Net Cash Flow Margin (MRQ)	3.38 %
Effective Tax Rate (TTM)	21.42 %

Management Effectiveness	Current
Return On Assets (TTM)	13.67 %
Return On Investment (TTM)	15.26 %
Return On Equity (TTM)	18.22 %
Dividend Yield	-
Pay out Ratio (TTM)	-

VIVO's Valuation
Price to Earnings PE Ratio (TTM)	21.56
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	3.97
Price to Sales (Expected)	-
Price to Book	3.59
PEG (TTM)	-

Per Share
Earnings (TTM)	1.41 $
Revenues (TTM)	7.67 $
Cash Flow (TTM)	0.3 $
Cash	1.73 $
Book Value	8.46 $
Dividend (TTM)	0 $

VIVO's Financial Strength
Quick Ratio	1.35
Working Capital Ratio	3.85
Leverage Ratio (MRQ)	0.26
Total Debt to Equity	0.07
Interest Coverage (TTM)	61.33
Debt Coverage (TTM)	2.1

• View Valuation Comparisons

• View Growth Rates Comparisons

VIVO's Efficiency
Revenue per Employee (TTM)	-
Net Income per Employee (TTM)	-
Receivable Turnover Ratio (TTM)	6.81
Inventory Turnover Ratio (TTM)	1.9
Asset Turnover Ratio (TTM)	0.74

VIVO's Profitability Ratio
Gross Margin (MRQ)	61.56 %
Operating Margin (MRQ)	32.49 %
Net Margin (MRQ)	25.85 %
Net Cash Flow Margin (MRQ)	3.38 %
Effective Tax Rate (TTM)	21.42 %

Management Effectiveness
Return On Assets (TTM)	13.67 %
Return On Investment (TTM)	15.26 %
Return On Equity (TTM)	18.22 %
Dividend Yield	-
Pay out Ratio (TTM)	-

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Meridian Bioscience Inc 's Segments

• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar WKSP's Profile Stock Price WKSP's Financials Business Description Fundamentals Charts & Quotes WKSP's News Suppliers WKSP's Competitors Customers & Markets Economic Indicators WKSP's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Industries

At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets

At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071